EULVIC – Eular Endorsed Course

October 03-05, 2024
Innsbruck, Austria | AC Hotel Innsbruck

Dear Colleagues,

Large vessel vasculitis (LVV) is the most common form of primary vasculitis comprising giant cell arteritis (GCA) and Takayasu arteritis (TA).

While a positive temporal artery biopsy has been the gold standard for the diagnosis of GCA for long time, and conventional angiography was used to diagnose TA, recent EULAR recommendations for the use of imaging in LVV point out the importance of imaging as a first-line test for diagnosing LVV. Imaging modalities used in LVV include ultrasound, magnetic resonance imaging (MRI), 18F-FDG positron emission tomography (PET) and computed tomography (CT).

The objective of this course is to improve the competency of rheumatologists and other professionals across the world to use these imaging techniques to assess patients with (suspected) LVV. In addition, skills to read histopathology of temporal arteries should be improved. This course is targeted at all professionals investigating and/or managing patients with LVV.

Apart from theoretical lectures, the course will contain live demonstrations and practical workshops. In practical ultrasound workshops, healthy individuals and LVV patients will be examined under supervision of tutors; in practical workshops on MRI, PET and CT, participants will work under supervision to analyse images. Histopathology will be taught in a theoretical and practical session.

Looking forward to welcome you to EULVIC 2024 in the Heart of the Alps!

Best regards

Christina Duftner and Christian Dejaco

Introduction by Christian Dejaco
Introduction by Wolfgang Schmidt

Permanentlink zu diesem Beitrag: